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Abstract 
The aim of this review is to assess the potential for neuroimaging measures to 
facilitate prediction of the onset of psychosis. Research in this field has mainly 
involved people at ‘ultra-high risk’ (UHR) of psychosis, who have a very high risk of 
developing a psychotic disorder within a few years of presentation to mental health 
services. 
The review details the key findings and developments in this area to date, and 
examines the methodological and logistical challenges associated with making 
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predictions in an individual subject in a clinical setting. 
Key words 
Psychosis prediction; Ultra High-Risk of psychosis; machine learning; Support 
Vector Machines; multimodal neuroimaging; multicentre neuroimaging studies; 
graph analysis 
Psychosis prediction and the ultra high-risk state 
Psychosis describes a syndrome that includes symptoms such as hallucinations, 
delusions, disorganised thought, and catatonia 1 2. Psychotic disorders are disorders 
that include symptoms of psychosis. The most common psychotic disorder is 
schizophrenia, however psychotic symptoms can occur in other disorders, for 
example in mood disorders such as bipolar and depression 3. 
Before the onset of symptoms that are severe enough to meet the clinical thresholds 
of a psychotic disorder, those affected experience subclinical psychotic symptoms 
and a decline in social / occupational functioning 4. Recognising the value of 
detecting and treating psychosis early 5, researchers and clinicians have developed 
the Ultra High-Risk (UHR) of psychosis criteria 6. UHR criteria are the most 
commonly used criteria for indicating risk of developing a psychotic disorder 7. 
Criteria for UHR status include attenuated psychotic symptoms and / or a brief 
limited intermittent psychotic episode and / or a genetically determined vulnerability, 
alongside deterioration in social and occupational functioning 7 8. UHR status comes 
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with the caveat that those who meet UHR status are selectively those who have 
come into contact with clinical services. This review uses the term UHR throughout. 
The UHR population is strikingly heterogeneous in terms of clinical outcomes. 
Follow-up studies 9  10 suggest that 7 years after clinical presentation, approximately 
a third of UHR subjects will have developed a psychotic disorder, with most 
transitions occurring in the first 2 years 11. Most of those who do not develop a 
psychotic disorder will have persistent attenuated symptoms and / or have 
developed another mental health disorder, whilst 14% will have recovered (see 
figure 1). 
Clinical intervention in the UHR group may reduce the likelihood of the onset of a 
psychotic disorder 12. However, as most UHR subjects do not develop a psychotic 
disorder, providing preventative treatment to all of those at risk is clinically 
inefficient. Identifying biomarkers that could be used to stratify the UHR group 
according to clinical outcome would enable the selective delivery of preventative 
interventions to the subgroup that would benefit the most. 
It is difficult to predict clinical outcomes in an UHR subject on the basis of their 
clinical features at presentation. Although the clinical assessment at presentation 
has good diagnostic validity for ruling out a future psychotic disorder (meta analytical 
sensitivity of UHR assessment = 0.96) 13, it has only a modest ability to rule in a 
future psychotic disorder (meta-analytical specificity of UHR assessment = 0.47) 13. 
There is thus a need to find other forms of assessment that can improve the 
specificity of psychosis prediction. 
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Figure 1. Colour intensifies as those with underlying vulnerability move closer 
towards disorder manifestation. Taken with permission from Fusar-Poli et al. (2015) 
14
 and based on data by Lin et al. (2011) 10. [Single column fitting image] 
Neuroimaging psychosis risk in the UHR population 
Neuroimaging techniques have provided a wealth of new information about the 
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pathophysiology of psychiatric disorders 10. Neuroimaging studies of the UHR 
population have implicated increased functional abnormalities in the prefrontal 
cortex (PFC), midbrain and medial temporal lobe (MTL) 15, structural abnormalities 
involving the PFC 16 17 and MTL 18, elevated dopaminergic activity in the striatum 19 
and midbrain 15, and abnormalities in levels of glutamate 20 and GABA 21. In general, 
these abnormalities are qualitatively similar but less severe than those seen in 
patients with psychotic disorders 5. 
These findings represent the difference between the UHR population as a whole 
and healthy controls. However, the comparison that is relevant to the prediction of 
psychosis onset is between the minority of UHR subjects that subsequently 
develops a psychotic disorder and the majority that does not. Cross-sectional 
neuroimaging studies comparing these two subgroups at presentation have reported 
differences in activation in the PFC, MTL, midbrain and caudate 10 22, in the volume 
of the MTL, PFC, and cingulate cortex 23 24, in the integrity of white matter pathways 
25
, and in glutamate levels in the caudate nuclei 26. Longitudinal studies with 
repeated measurements before and after the onset of a psychotic disorder have 
described progressive changes in MTL and PFC volume 14 27 28, in white matter 
volume 29 and integrity 30, and in striatal dopamine function 31. These changes were 
not evident in UHR subjects who did not develop a psychotic disorder. 
Neuroimaging findings associated with the transition to psychosis have 
understandably been the focus of most studies to date, and most studies have 
subdivided UHR samples into groups who did or did not develop a psychotic 
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disorder. However, this subdivision is potentially misleading, as the subgroup that 
does not develop a psychotic disorder is not homogeneous: in some subjects, their 
presenting features resolve, such that they no longer meet the UHR criteria, 
whereas in others their symptoms persist. A further subgroup develop mental health 
disorders other than psychosis, particularly depression and anxiety (Figure 1) 9 10. 
Identifying neuroimaging measures that predict these other outcomes is also of 
interest. For example, determining the factors that predict recovery may improve our 
understanding of what determines resilience to mental illness, and could allow 
clinicians to avoid giving unnecessary treatments to people who would be very likely 
to recover without any intervention. Recent studies have begun to examine 
predictors of recovery in the UHR population, but at present this literature is still 
relatively small 32 33. 
Outcome can also be defined in terms of level of functioning, as opposed to clinical 
status. Long term follow up studies suggest that an UHR individual’s level of social 
and vocational functioning can sometimes be more clinically meaningful than their 
diagnostic category 34. Studies have also recently begun to examine the relationship 
between neuroimaging measures and functional outcomes 32 35 36. 
Multi-centre studies 
Although the results have been of great interest, to date most neuroimaging studies 
in UHR subjects have involved small sample sizes 37. Traditionally, mental health 
services have not engaged people with psychotic symptoms until after development 
of a first episode of a psychotic disorder. The concept of clinical provision for UHR 
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individuals is relatively new, and specialised services for this group are still limited to 
a minority of psychiatric centres. As UHR subjects are usually ascertained through 
specialised clinical services, this constrains recruitment to research studies. This 
can lead to studies being underpowered, particularly if the hypotheses relate to a 
specific clinical outcome (such as the onset of a psychotic disorder) that is only 
evident in a subset of the total UHR sample. This issue can be addressed through 
the recruitment of UHR subjects from multiple different sites: a number of such 
multi-centre studies involving neuroimaging have recently been completed 15 19 and 
several others are on-going 38 39 40. 
Although multi-centre studies can provide greater statistical power, there is a 
potential danger of introducing bias from between-centre differences in image 
acquisition and processing. For example, differences in scanning protocols 41 42 and 
scanning hardware 43 can cause significant variability in results, as can upgrades of 
software and hardware within centres 44. These effects may be reduced through the 
harmonisation of scanning parameters and quality control across centres, and by 
the development of acquisition protocols that are specifically designed to minimise 
between centre variance, such as those used in the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) 45 44. 
Nevertheless, some between-centre variance is inevitable. Some studies quantify 
this by directly comparing neuroimaging data acquired from a group of volunteers 42 
46
 
47
 
48
 or identical phantoms at different sites 49. Researchers have also used 
methods of post hoc statistical correction to adjust for between scanner variance 50. 
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However, if a predictive tool is to be employed at a variety of sites in a clinical 
setting, it may not be feasible to use phantoms or travelling subjects to control for 
between-site effects. In this case, the use of methods for post hoc correction may be 
more realistic. 
Machine learning for individual prediction of psychosis transition 
In clinical practice, predictions about the risk of psychosis need to be made using 
data from a single subject. However, most studies that have identified neuroimaging 
features that are associated with the onset of a psychotic disorder in UHR samples 
have described average differences between groups, which although statistically 
significant, describe two highly overlapping populations. In this context, individual 
inference has a limited utility. This has led to research on the application of 
statistical approaches that use multivariate patterns rather than group level 
differences, which are more suited to making individual level inferences. These 
approaches include machine-learning methods 51, such as Random Forests 52, 
Support Vector Machines (SVMs) 53, Linear Discriminant Analyses 54, and K-Nearest 
Neighbour algorithms 55. Machine learning methods allow for individual classification 
and are sensitive to subtle effects that would go unnoticed using traditional 
univariate analyses 56. 
The method that has been most widely applied to neuroimaging data is the SVM 57, 
which may reflect its comparatively better performance with highly dimensional data 
58
. One reason for this is that SVMs base classification decisions on the most useful 
data points (see figure 2), which helps to overcome some of the difficulties 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 9 
associated with modelling highly dimensional data 53. 
The support vector machine (SVM) is a supervised classification algorithm that 
learns from an initial ‘training’ dataset to classify new cases into two or more groups 
56
. For example, a SVM can be trained on a dataset of baseline neuroimaging 
measurements from UHR subjects defined by whether they subsequently developed 
a clinically defined outcome or not, and can then be applied to a new sample of 
UHR individuals 56 (see figure 2). 
Figure 2. A. A classification boundary is created based on the maximum margin 
space between the two distributions of data points. Only data points near the margin 
(the support vectors) affect the classification boundary, facilitating a good 
generalization of the classification model. B. If it is not possible to create a linear 
classification boundary, a kernel function can be used to transform the data into 
higher dimensional space where classes become linearly separable. C. Schematic 
of SVM training and testing with neuroimaging data. In training, information from the 
two groups, or classes, is used to make a classification algorithm based on the 
predictive differences of the two groups. In testing, the algorithm is applied to data 
from a new subject to classify them as belonging to either group. [1.5 column fitting 
image] 
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A SVM is validated by demonstrating that it can classify individuals in a sample 
independent of the dataset it was originally trained on. Ideally this is done using a 
second dataset that has been acquired separately from the original 56. Validation 
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can also be attempted without a second dataset, for example by splitting the original 
sample (repeatedly), with one portion being used as the training dataset and other 
portions being used for cross-validation (e.g. k-fold cross-validation 59). However, 
any overlap between the training and test datasets will result in the model over-
fitting 60. This issue can be addressed by using methods that ensure separation 
between the training and test data, such as repeated double cross-validation 61.  
Nevertheless, splitting a single sample for training and validation will include 
sampling error in the classification, and there is a risk that the original sample is 
atypically easy or difficult to classify, particularly when the sample is small. 
Preliminary results from the application of SVMs in UHR samples have been 
promising. A SVM trained on volumetric MRI data was able to distinguish between 
UHR subjects who later transitioned and a combined group of non-transitioning UHR 
subjects and healthy controls with an accuracy of 88%, and between UHR who did 
not transition and a combined group of healthy controls and UHR who did transition 
with an accuracy of 86% 62. A subsequent study used voxel-level MRI measures of 
grey matter volume to distinguish between UHR participants who did or did not go 
on to develop a psychotic disorder with an accuracy of 84.2% 63. 
To date, applications of SVMs to UHR samples have used cross-validation methods 
within a single sample 63 64 rather then the ideal validation method of using a second 
independent dataset. This partly reflects the fact that it is logistically difficult to 
ascertain large samples of UHR subjects with neuroimaging data and initial studies 
did not have access to another large dataset with comparable neuroimaging 
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measures. One study has used a SVM on two small datasets from different centres, 
although these employed different UHR criteria and MRI protocols. This reported an 
accuracy of classification of UHR transition outcomes of 80% 65, and also suggested 
that between centre effects could be minimised by using a sample pooled across 
both centres for training and testing 65.  
The use of larger UHR samples would reduce (though not completely eliminate 66) 
the risk of models over-fitting the data 67. A model that over-fits the data is one that 
has been influenced by random error and noise in the training data to the extent that 
it does not accurately reflect the underlying phenomenon being studied 68. Over-
fitting is a particular concern in models where the number of dimensions greatly 
outweighs the sample size and in highly complex models. 
In addition to ensuring a sufficient sample size, over-fitting can be reduced by 
limiting the analysis to the most predictive features, using dimensionality reduction 
or subset selection techniques 69. It is also possible to use the results of previous 
research to limit predictive models to regions of interest 70, although this relies on 
the assumption that findings from mass univariate approaches are applicable to a 
multi-variate analyses. 
The size of the sample studied also impacts on the generalizability of the findings. 
Small samples may result in higher fluctuations of accuracy estimates when using 
neuroimaging data in SVMs, suggesting poor model generalizability 71. In addition, 
larger sample sizes are less affected by sampling effects and capture more of the 
population’s heterogeneity, making them more likely to be representative of the 
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population being studied 72. The numerous advantages of studying large samples 
has led to a wave of multicentre neuroimaging studies that are recruiting UHR 
subjects from several different centres, often using standardised image acquisition 
protocols 38 39 40. A further development has been the HARMONY initiative, which is 
designed to standardise neuroimaging, clinical, and electrophysiological 
assessments across these different multi-centre UHR consortia 73. As well as the 
opportunity to pool data to create even larger datasets, this will allow a SVM 
developed using one large sample to be validated on large independent datasets 
collected by other consortia. 
There is also scope for the modification and optimisation of the machine learning 
methods that have been used in UHR subjects. For instance, SVMs can be modified 
to incorporate different statistical components. This includes the application of 
Bayesian probability and ‘fuzzy logic’ to SVMs, which have been used to create 
Relevance vector machines (RVM) 74 and Fuzzy SVMs 75 respectively. Both of these 
methods can be used to minimise the effect of outliers on the training phase of a 
machine 74 75.  
By introducing a different loss function 76 support / relevance vector algorithms can 
also be used in regression (Support Vector Regression: SVR 77; Relevance Vector 
Regression: RVR 74), which allows for classification in terms of a continuous, as 
opposed to a categorical outcome. Tognin et al. (2014) used this approach to show 
that symptom progression in UHR subjects could be predicted using a RVR applied 
to cortical thickness at presentation 78. Regression-based machine learning has also 
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been applied to neuroimaging data to predict ‘brain age’, whereby individual brains 
are characterised according to indices of maturity 79 80. Such examples show high 
accuracy in predicting age based on MRI-derived brain descriptors in large-scale 
cohorts of healthy adolescents and adults 81. In patient populations, Koutsouleris et 
al. (2013 79, 2015 82) demonstrated ‘accelerated aging effects’ using volumetric MRI 
data in different patients groups, including UHR participants. In a longitudinal study, 
Schnack et al. (2016) showed that aging of the brain continues to accelerate during 
the first five years after onset of a psychotic disorder 83. Brain age estimation has 
also been conducted with resting state fMRI data in a large sample of children, 
suggesting delayed maturation to predict the presence of mental health problems 84. 
These findings suggest that machine learning-based biomarkers for psychosis 
prediction could be improved by taking account of the potential impact of 
neurodevelopmental changes on neuroimaging data. For example, predictors 
trained on UHR samples that are limited to subjects of a narrow age range may not 
be generalizable to samples that include subjects outside that range, who are at 
different stages of development. This issue may be particularly relevant to prediction 
in UHR samples, as these can include subjects within a wide age window (14-40 
years), but there can be marked differences in the age of those enrolled at different 
centres, reflecting variations in the way that UHR subjects are recruited. For 
example, the mean age in UHR subjects recruited through adolescent or youth 
mental health services is significantly lower than in subjects enrolled through adult 
early detection services, and age therefore varies across studies 85. Large-scale 
collaborative efforts that include samples with different age ranges such as 
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HARMONY 73 may help to address the issue of ‘neurodevelopmental heterogeneity’ 
in the UHR state. 
Multimodal prediction of psychosis onset 
A feature of machine learning methods that has yet to be fully exploited in the 
UHR field is that their use is not restricted to neuroimaging data: they can be 
applied to multiple data modalities 86. The integration of data from different 
modalities may be particularly useful in predicting the onset of psychosis, as it is 
the result of interactions between a diversity of genetic, environmental and 
neurobiological factors 87. Moreover, multimodal neuroimaging studies in UHR 
subjects indicate that the normal relationships between glutamate and grey 
matter volume (MRS and sMRI) 88, glutamate and functional activity (MRS and 
fMRI) 89 90 91, glutamate and dopamine (MRS and PET) 92 and dopamine and 
functional activity (PET and fMRI) 15 93 are perturbed. These observations are 
consistent with animal models of psychosis, which also implicate interactions 
between the medial temporal cortex and the striatum and midbrain, and 
dopaminergic, glutaminergic and GABAergic dysfunction 94. 
To date, most SVM studies in UHR subjects have involved data from a single 
neuroimaging modality (MRI), although the impact of introducing additional data 
modalities has recently been explored 86. This partly reflects the logistical demands 
associated with acquiring multi-modal neuroimaging data in samples that are large 
enough to permit comparison of subgroups with different clinical outcomes 95. 
However, ongoing multi-centre studies in this field involve a range of different 
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neuroimaging modalities, as well as genetic, clinical and cognitive data, and will be 
able to recruit samples large enough to assess predictors of outcomes. 
There is some evidence that combining modalities may improve the prediction 
accuracy of machine learning classifiers. In predicting the onset of Alzheimer’s 
disease from mild cognitive impairment, combining neuroimaging and 
neurocognitive measures increased the accuracy of SVMs beyond that of a single 
modality SVM 96 97. Conversely, a study of UHR, FEP and healthy control subjects 
found that prediction in some comparisons was more accurate when using a single 
neuroimaging modality compared to multiple modalities 86. The authors suggest that 
this may have been a result of an absence of complementary information in the 
additional modalities 86. 
A further consideration in the use of multiple data modalities is practicality and cost. 
Data collection with some imaging modalities, such as PET, is expensive, can 
involve long acquisition times or may require specialist equipment and technical 
support 44. On the other hand, the collection of volumetric MRI, blood samples, and 
behavioural measures is feasible in many centres, making them the most viable 
options for wider clinical use. However, if predictive findings identified using 
relatively sophisticated neuroimaging techniques were closely correlated with 
measures in other domains, the latter could then serve as more accessible and less 
expensive proxy measures for a neuroimaging gold standard. For example, in the 
prediction of the onset of Alzheimer’s disease, the level of past education and 
occupational functioning are putative proxy measures for PET data on brain glucose 
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metabolism 98. 
Consortium recruiting large samples of UHR participants will collect a range of 
imaging, blood-based (bio-marker and genetic), and questionnaire based data 38 39 
40
. This is a benefit both due to the range of data-types available for predictive 
modelling and because it allows for an understanding of the interactions between 
different biological systems, which may be crucial to predicting the onset of 
psychosis. For example, it has been suggested that the hypothalamic-pituitary-
adrenal axis acts as the mediating system for the influence of stress on psychotic 
symptoms, a system involving both hormones / inflammatory markers, brain areas, 
and psychological stress 99 100 101 102. 
Another possibility is that less expensive measures may provide predictive models 
without the need for imaging. Promising preliminary results have been found using 
machine learning methods on blood-based biomarkers (mainly hormones and 
inflammatory markers) for the prediction of a future psychotic disorder 103 104. These 
early studies used around 15-30 blood-based markers 103 104, which gives an 
appropriate number of degrees of freedom for a predictive model, a benefit over 
models based on highly dimensional neuroimaging or genetic data. Given that 
blood-based biomarkers would likely reflect psychosis risk due to their interface with 
the brain however, predictive models using both imaging and blood-based 
biomarkers could perform better than each modality alone. 
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Graph analysis 
Psychosis can be conceptualised as disorder of brain dysconnectivity 105 106 107, and 
neuroimaging studies suggest that both functional and structural connectivity are 
altered in people at UHR. Moreover, differences in connectivity have also been 
identified between UHR subjects who later develop a psychotic disorder and those 
who do not 108 109, suggesting that measures of connectivity may be useful in 
predicting the onset of psychosis 110. 
There are several methods that can be used to assess connectivity, but one of the 
most promising involves the application of network modelling approaches such as 
graph theory (GT), which forms graphs representing patterns of connectivity 
between brain areas 111. Brain graphs are conceptualised as comprising nodes 
(neuroanatomical regions) that are connected by edges (structural/functional 
connections) 112. This allows for connectivity to be characterised in terms of 
functional segregation (e.g. modularity), functional integration (e.g. shortest path 
length (see figure 3), global efficiency), small world, network motifs, centrality (e.g. 
degree), and network resilience (e.g. degree distribution) 113. Graph analysis thus 
provides information on the integrative features of brain networks.  
Brain graphs in healthy participants suggest that the brain is normally organised 
in a way that maximises the integration of the whole network, while allowing for 
the segregation of specific brain regions. Brain graphs typically show a modular 
organization, such that the network can be broken down into smaller sub 
networks 111, with modules specialized for specific computational processes 114 
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Within brain networks, certain nodes, termed hubs, are much more connected 
than others 111, and form ‘rich clubs’ 115 (see figure 3). Hubs have more long 
distance connections and higher metabolic demands than regular nodes 116 117, 
and because of their strategic position in the network are thought to have an 
important role in brain functioning 118 119.  
Figure 3. A. Visualisation of a brain graph with 90 defined nodes, parcellated 
according to the Automatic Anatomical Labelling atlas 120. B. Simple example of 
shortest path length. Shortest path between the two blue nodes highlighted by blue 
edges. C. Example of a network that shows community structure (sub-networks 
highlighted in grey) with hubs (purple nodes) connected in a rich club (purple 
edges). [Single column fitting image] 
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Graph analysis of neuroimaging data in patients with schizophrenia suggests that 
the disorder is associated with decreased efficiency 121, clustering and small 
worldness 122, and MRI abnormalities in psychotic disorders appear to be 
preferentially concentrated in hub regions 123 124. Abnormal GT measures have also 
been associated with elevated psychotic symptomatology in a sample of UHR 
participants 125. 
The mathematical functions of machine learning cannot easily be applied to graphs 
however 126. To date, studies that have used graph analysis metrics for machine 
learning have used whole brain graph theory metrics rather than representing the 
characteristics of individual nodes and / or edges 127 128. In answer to this, methods 
for transforming graph data in to real vector space have been proposed, allowing for 
the application of machine learning classification and pattern recognition methods to 
graph data 126 129. For instance, techniques such as graph embedding allow for 
vector representation of nodes or edges, which can additionally incorporate graph 
topological features 130. Additionally, graph kernels carry the possibility of applying 
graphs to kernel based machines such as SVMs 126. Developments in this area are 
on-going 131 but these methods have not yet been validated in brain graphs, and it 
remains to be seen whether the complex and noisy graphs that are derived from 
neuroimaging data can be adequately represented 130. 
Conclusions 
Because it is difficult to predict whether a UHR subject will develop a psychotic 
disorder on the basis of a clinical assessment, there is a need for biomarkers that 
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can help to predict outcomes in this group. Neuroimaging measures have the 
potential to facilitate the prediction of outcomes in UHR subjects. Further progress in 
their application requires the development of methods that permit prediction using 
data from an individual subject, and their validation in large independent samples. 
The extent to which the accuracy of prediction is enhanced by using more than one 
type of imaging data, or incorporating non-imaging data remains to be determined. 
Many of these issues are currently being addressed in multi-centre neuroimaging 
studies in UHR subjects. 
The on-going effort to use neuroimaging to facilitate prediction of the onset of 
psychosis provides a good example of a recent shift in the focus of psychiatric 
neuroimaging research, from descriptive studies to investigations with an explicitly 
translational objective. 
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Highights 
• Machine learning methods allow for prediction of psychosis outcomes in 
individuals. 
• Current multicentre studies seek to recruit sufficient samples for ML prediction. 
• Multiple modalities can be incorporated into ML predictive models. 
• ML methods can be used to predict continuous outcomes. 
• ML can incorporate graph analysis if data is transformed into vector space. 
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